HIGHLIGHTS   |  March 14, 2020   FDA Grants Fast Track Designation to Tipifarnib to Treat Lymphoma Kura Oncology’s leading drug candidate, tipifarnib, was granted fast track designation by the FDA to treat adults of T-cell lymphomas. Read more   Mark Schroeder, MD, Discusses Treatment Options for Acute GvHD Mark Schroeder, MD, detailed 3 different potential treatments for acute graft versus host disease. Read more   In Case You Missed It

Using HDAC3 Inhibitors to Reverse CREBBP Mutations in Lymphomas This research could potentially pave the way for possible immunotherapy approaches for common forms of non-Hodgkin lymphoma. Read more